Evaxion Biotech A/S
EVAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,567 | -$22,125 | -$23,169 | -$24,532 |
| Dep. & Amort. | $607 | $615 | $571 | $344 |
| Deferred Tax | -$813 | -$984 | -$998 | -$190 |
| Stock-Based Comp. | $357 | $479 | $942 | $1,379 |
| Change in WC | $520 | $1,562 | -$2,877 | $1,237 |
| Other Non-Cash | -$3,044 | $2,762 | -$243 | -$171 |
| Operating Cash Flow | -$12,940 | -$17,691 | -$25,774 | -$21,933 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$87 | -$292 | -$1,300 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$3 | -$6 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $24 | $30 |
| Other Inv. Act. | $0 | $0 | -$0 | -$60 |
| Investing Cash Flow | -$3 | -$93 | -$268 | -$1,330 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,136 | -$632 | $7,425 | -$289 |
| Stock Issued | $16,550 | $9,168 | $428 | $53,854 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,285 | $2,155 | $0 | -$3,760 |
| Financing Cash Flow | $13,129 | $10,691 | $7,853 | $49,805 |
| Forex Effect | $183 | -$508 | -$793 | -$210 |
| Net Chg. in Cash | $369 | -$7,601 | -$18,982 | $26,332 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,583 | $13,184 | $32,166 | $5,834 |
| End Cash | $5,952 | $5,583 | $13,184 | $32,166 |
| Free Cash Flow | -$12,940 | -$17,778 | -$26,066 | -$23,293 |